Tellabs Names Acting CEO
Tellabs Inc. (Nasdaq: TLAB; Frankfurt: BTLA) has named Dan Kelly, executive vice president of global products, as its acting president and CEO.
CEO Rob Pullen is battling colon cancer, as he revealed to the world in April. On Wednesday, Tellabs reported that Pullen has undergone surgery. Here's the full text of the chairman's letter that was released by the company:
Dear Stockholders, Customers, Employees and Friends,
As Tellabs CEO Rob Pullen committed in his April 20 message, I am providing an update on his health.
Rob has been continuing treatment for cancer, and he recently had surgery. He remains in the hospital in stable condition and is under continuing care for his recovery.
We all wish Rob a quick and full recovery.
During Rob's recovery, Tellabs Board of Directors has appointed Dan Kelly as acting president and CEO.
Michael J. Birck
— The Staff, Light Reading